Skip to main content
NVDA-2.10%AAPL+2.69%GOOGL+0.24%MSFT+0.56%AMZN+0.12%TSM-0.81%SPCX+2.02%AVGO+0.03%META-0.22%TSLA-0.47%SKHY-3.57%MU-4.31%BRK-B-0.24%LLY+0.25%JPM-0.60%WMT+0.20%AMD-2.67%V-0.09%XOM+0.78%ASMLa-1.66%JNJ-0.19%INTC-4.47%MA-0.42%0700.HK-1.94%1398.HK+0.79%ORCL-2.97%ABBV+0.61%BAC-0.65%CSCO-0.91%CVX0.00%COST-0.01%KO+0.78%LRCX-4.62%CAT-1.46%AP2d-1.55%0005.HK-0.78%AMAT-2.16%UNH-0.23%HSBA.L-1.30%DELL-3.64%PG-0.05%MS-0.60%GE-0.47%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.05%HD-1.35%0939.HK+1.66%GS-0.76%NZDJPY-2.49%AUDJPY-1.75%CHFJPY-1.55%NZDCAD-1.40%EURNZD+1.34%GBPNZD+1.32%USDJPY-1.27%NZDUSD-1.25%EURJPY-1.20%GBPJPY-1.18%CADJPY-1.10%NZDCHF-0.97%USDZAR+0.89%USDNOK+0.82%EURZAR+0.79%USDSEK+0.77%AUDNZD+0.77%GBPZAR+0.74%EURNOK+0.72%AUDCAD-0.68%EURSEK+0.67%AUDDKK-0.60%CHFNOK+0.59%EURAUD+0.56%GBPAUD+0.55%USDTHB+0.54%CHFSEK+0.53%AUDUSD-0.49%AUDSGD-0.48%CADCHF+0.43%USDMXN+0.43%GBPTRY+0.41%NOKJPY-0.35%USDPLN+0.35%GBPCHF+0.35%EURCHF+0.34%GBPHKD+0.32%NZDSGD-0.31%USDCHF+0.29%GBPMXN-0.28%SGDJPY+0.25%EURPLN+0.25%USDSGD+0.21%AUDCHF-0.21%USDILS+0.16%USDCAD-0.15%AUDNOK+0.12%NZDMXN-0.12%PLNJPY+0.12%EURSGD+0.11%EURHKD-0.11%USDTRY+0.11%GBPCAD-0.10%USDDKK+0.10%EURCAD-0.10%EURCZK-0.08%USDCNH+0.08%GBPUSD+0.08%EURUSD+0.06%GBPSGD+0.06%USDCOP-0.04%CHFSGD-0.02%USDHKD+0.01%EURGBP+0.01%EURDKK0.00%EURCNH0.00%XPTUSD-5.22%UKOIL+4.94%USOIL+4.58%HG1-4.54%GAGUSD-4.20%XAGUSD-4.20%GAUUSD-0.80%XAUUSD-0.80%COTTON+0.67%S1+0.49%XNGUSD+0.48%COFFEE-0.46%BTCUSD-1.38%ETHUSD-0.57%USDTUSD-0.02%XRPUSD-2.75%SOLUSD-1.67%TRXUSDT+0.03%ZECUSDT-8.60%DOGEUSD-2.91%XMRUSDT-0.86%LINKUSD-1.49%XLMUSD-1.82%BCHUSDT-9.83%LTCUSD-1.56%UNIUSD-2.61%TONUSD+24.88%HBARUSDT-2.10%SUIUSD-3.76%TAOUSDT-4.65%AAVEUSD-2.57%DOTUSDT-2.67%ICPUSDT-1.78%ONDOUSDT-3.23%WLDUSDT-2.67%ATOMUSDT-3.51%ARBUSDT-0.87%JUPUSDT-4.25%INJUSDT-3.68%STXUSDT-4.16%FETUSDT-3.86%TIAUSDT-1.65%PYTHUSDT-1.33%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.02%WIFUSDT-5.38%OPUSDT-3.00%POLUSDT-4.56%IOTAUSDT-3.87%AXSUSDT-2.36%FARTCOINUSDT-4.03%EOSUSDT-2.91%DYDXUSDT-2.49%ORDIUSDT-1.37%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.10%AAPL+2.69%GOOGL+0.24%MSFT+0.56%AMZN+0.12%TSM-0.81%SPCX+2.02%AVGO+0.03%META-0.22%TSLA-0.47%SKHY-3.57%MU-4.31%BRK-B-0.24%LLY+0.25%JPM-0.60%WMT+0.20%AMD-2.67%V-0.09%XOM+0.78%ASMLa-1.66%JNJ-0.19%INTC-4.47%MA-0.42%0700.HK-1.94%1398.HK+0.79%ORCL-2.97%ABBV+0.61%BAC-0.65%CSCO-0.91%CVX0.00%COST-0.01%KO+0.78%LRCX-4.62%CAT-1.46%AP2d-1.55%0005.HK-0.78%AMAT-2.16%UNH-0.23%HSBA.L-1.30%DELL-3.64%PG-0.05%MS-0.60%GE-0.47%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.05%HD-1.35%0939.HK+1.66%GS-0.76%NZDJPY-2.49%AUDJPY-1.75%CHFJPY-1.55%NZDCAD-1.40%EURNZD+1.34%GBPNZD+1.32%USDJPY-1.27%NZDUSD-1.25%EURJPY-1.20%GBPJPY-1.18%CADJPY-1.10%NZDCHF-0.97%USDZAR+0.89%USDNOK+0.82%EURZAR+0.79%USDSEK+0.77%AUDNZD+0.77%GBPZAR+0.74%EURNOK+0.72%AUDCAD-0.68%EURSEK+0.67%AUDDKK-0.60%CHFNOK+0.59%EURAUD+0.56%GBPAUD+0.55%USDTHB+0.54%CHFSEK+0.53%AUDUSD-0.49%AUDSGD-0.48%CADCHF+0.43%USDMXN+0.43%GBPTRY+0.41%NOKJPY-0.35%USDPLN+0.35%GBPCHF+0.35%EURCHF+0.34%GBPHKD+0.32%NZDSGD-0.31%USDCHF+0.29%GBPMXN-0.28%SGDJPY+0.25%EURPLN+0.25%USDSGD+0.21%AUDCHF-0.21%USDILS+0.16%USDCAD-0.15%AUDNOK+0.12%NZDMXN-0.12%PLNJPY+0.12%EURSGD+0.11%EURHKD-0.11%USDTRY+0.11%GBPCAD-0.10%USDDKK+0.10%EURCAD-0.10%EURCZK-0.08%USDCNH+0.08%GBPUSD+0.08%EURUSD+0.06%GBPSGD+0.06%USDCOP-0.04%CHFSGD-0.02%USDHKD+0.01%EURGBP+0.01%EURDKK0.00%EURCNH0.00%XPTUSD-5.22%UKOIL+4.94%USOIL+4.58%HG1-4.54%GAGUSD-4.20%XAGUSD-4.20%GAUUSD-0.80%XAUUSD-0.80%COTTON+0.67%S1+0.49%XNGUSD+0.48%COFFEE-0.46%BTCUSD-1.38%ETHUSD-0.57%USDTUSD-0.02%XRPUSD-2.75%SOLUSD-1.67%TRXUSDT+0.03%ZECUSDT-8.60%DOGEUSD-2.91%XMRUSDT-0.86%LINKUSD-1.49%XLMUSD-1.82%BCHUSDT-9.83%LTCUSD-1.56%UNIUSD-2.61%TONUSD+24.88%HBARUSDT-2.10%SUIUSD-3.76%TAOUSDT-4.65%AAVEUSD-2.57%DOTUSDT-2.67%ICPUSDT-1.78%ONDOUSDT-3.23%WLDUSDT-2.67%ATOMUSDT-3.51%ARBUSDT-0.87%JUPUSDT-4.25%INJUSDT-3.68%STXUSDT-4.16%FETUSDT-3.86%TIAUSDT-1.65%PYTHUSDT-1.33%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.02%WIFUSDT-5.38%OPUSDT-3.00%POLUSDT-4.56%IOTAUSDT-3.87%AXSUSDT-2.36%FARTCOINUSDT-4.03%EOSUSDT-2.91%DYDXUSDT-2.49%ORDIUSDT-1.37%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%
AL

Anavex Life Sciences Corp. (AVXL)

NASDAQ • Healthcare

$2.75
-$0.1 (-3.5%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$2.84
Previous Close$2.75
Day Range$2.74 - $2.9
Avg. Volume (3M)729.4K
Market Cap$245.9M
52 Week Range
$2.26$10.38
Next EarningsIn 75 daysNov 24, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$24M
EPS (TTM)
-$0.26
ROA (TTM)
-20.01%
Current Ratio
15.62

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+40.0%Q1 2026-$0.06
+200.0%Q3 2026$0.08
+62.5%Q3 2026-$0.03
Next

Nov 24

in 75 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Anavex Life Sciences Corp.

Anavex Life Sciences Corp. is a NASDAQ-listed biotechnology company focused on developing therapeutic drug candidates for central nervous system conditions. The company is still at a clinical stage rather than a commercial one, with a drug pipeline centered on neurodegenerative, neurodevelopmental, pain, and oncology programs.

Name
Anavex Life Sciences Corp.
CEO
Terrie Kellmeyer
Website
www.anavex.com
Industry
Healthcare
Year Founded
2004
Employees
34

Today's Snapshot

AI-generated

AVXL is trading 3.6% lower at 2.65, while its sector was flat. Anavex planned a discussion about including children in a Rett syndrome trial.

Trading Volume

Below 10d avg (592.2K)

208.9K

vs S&P 500 Today

Strong Underperformance

-3.07%

Updated: September 10, 2026 at 16:59 UTC

Technical Indicators

1 Buy1 Neutral6 Sell
AVXL is marked as a sell with the price under multiple moving averages, including the 200-day, which underscores longer-term weakness while short-term averages also sit above current levels. Momentum and MACD readings are negative and the CCI is notably below zero, even as the RSI remains in the high 30s and stochastic signals show extreme lows. ADX around the mid-teens indicates limited trend strength, ATR near 6.4% signals elevated volatility, and OBV is deeply negative. Technical takeaway: prevailing sell bias from negative momentum, high volatility and sustained outflows.
All signals
  • EMA (5 indicators)$2.87 - $4.05
    Sell
  • RSI (14)38.97
    Neutral
  • Stochastic %K (14, 3, 3)3.78
    Buy
  • MACD Level (12, 26)-0.06
    Sell

Peers & Related Assets

ERASErasca, Inc.
$15.7-3.6%
MBXMBX Biosciences, Inc. Common Stock
$62.91-0.1%
ABSIAbsci Corporation
$8.65-2.9%
MGTXMeiraGTx Holdings plc
$13.26-2.0%
ARVNArvinas, Inc.
$8.76-3.5%
RGNXREGENXBIO Inc.
$8.73-0.3%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.